For most surgeries, aspirin is typically restarted within 8 to 10 days, once the immediate bleeding risk has dropped. But the actual timing depends heavily on why you take aspirin, what kind of surgery you had, and whether your surgeon sees signs that bleeding has stopped. Some people never need to stop it at all.
The General Timeline: 8 to 10 Days
A large trial published in the New England Journal of Medicine studied aspirin use around noncardiac surgery and found that the period of highest bleeding risk falls in the first week after an operation. By days 8 to 10, that risk has diminished considerably, making it the most practical window for people on a long-term aspirin regimen to resume their usual dose. In the study, patients in the “continuation” group took 100 mg daily for 7 days post-surgery before switching back to their regular regimen.
This 8-to-10-day window is a useful baseline, but it’s not universal. Your surgeon’s specific instructions will depend on how much you bled during the procedure, how quickly your wound is healing, and the reason you were taking aspirin in the first place.
If You Have a Coronary Stent
Patients with coronary stents are in a different category entirely. The American College of Cardiology and American Heart Association recommend that aspirin be continued through surgery whenever possible for people with coronary artery disease. If it absolutely must be stopped, the guideline is to restart it as soon as possible after the procedure, not days later. This is a Class I recommendation, the strongest level.
The reason is straightforward: stents, especially drug-eluting stents, carry a risk of blood clots forming inside them if antiplatelet protection lapses. That risk is far more dangerous than the bleeding risk from aspirin. If you have a stent and are facing surgery, the goal is usually to keep aspirin going throughout or restart it within 24 to 48 hours. Elective noncardiac surgeries should ideally be delayed at least 6 months after a drug-eluting stent is placed, or 30 days after a bare-metal stent, to avoid this dilemma altogether.
Hip and Knee Replacements
Joint replacement surgery has its own protocol because blood clots in the legs are a major concern after these procedures. In a New England Journal of Medicine trial, patients undergoing total hip or knee replacement received a prescription blood thinner for the first 5 days, then switched to 81 mg of aspirin daily starting on postoperative day 6. After knee replacement, aspirin continued for an additional 9 days. After hip replacement, it continued for 30 days.
In this context, aspirin isn’t being “restarted” so much as introduced as part of blood clot prevention. If you were already taking daily aspirin before your joint replacement, your orthopedic surgeon will fold that into the overall clot-prevention plan, and the transition typically happens around that day-5-to-day-6 mark.
Minor and Dental Procedures
For many minor procedures, you may not need to stop aspirin at all. Research on dental extractions, including single-tooth removal, has found that antiplatelet therapy can safely continue throughout the procedure. The small amount of bleeding from minor oral surgery is manageable with local measures like gauze pressure and specialized dressings, and the cardiovascular risk of stopping aspirin outweighs the minor bleeding risk.
The same logic applies to many dermatological procedures and other low-bleeding-risk surgeries. If your doctor tells you to keep taking aspirin through a minor procedure, that’s consistent with current evidence. There’s no restart timeline because there was no interruption.
What Your Surgeon Looks For
Rather than picking a fixed number of days, many surgeons base the restart decision on whether your body has achieved hemostasis, meaning your surgical site has stopped actively bleeding and clotting is stable. The practical signs include no drainage from the wound, stable blood counts, and no expanding bruising or swelling at the surgical site.
For patients who experienced gastrointestinal bleeding (not surgical bleeding), the timeline is more specific. If an endoscopy shows a clean-based ulcer with no active bleeding, guidelines from Asia-Pacific gastroenterology groups recommend restarting antiplatelet agents as early as day 1. If the bleeding required endoscopic treatment to control, European guidelines recommend waiting about 3 days. A joint consensus from cardiology and gastroenterology organizations places the window at 3 to 7 days after bleeding has stopped.
The underlying principle across all these scenarios is the same: aspirin goes back on once the bleeding risk at the surgical or bleeding site is clearly under control. For people who take aspirin to prevent heart attacks or strokes (secondary prevention), delaying too long carries its own danger. One review found that resuming low-dose aspirin after achieving hemostasis was associated with reduced mortality over the following two months, even though it slightly increased the chance of re-bleeding at the original site.
Why the Reason You Take Aspirin Matters
The urgency of restarting depends on whether you take aspirin for primary prevention (reducing risk when you haven’t had a cardiovascular event) or secondary prevention (protecting against a second heart attack or stroke). Secondary prevention patients face a much higher risk from stopping aspirin, so their restart timelines tend to be shorter and more aggressive.
If you take aspirin because you’ve had a heart attack, stroke, or stent placement, the clinical priority shifts toward getting you back on it quickly, sometimes within 24 hours if bleeding is controlled. If you take it for general prevention without a history of cardiovascular events, there’s more flexibility to wait the full 8 to 10 days or even longer if your surgeon has concerns about the wound.
The dose you were taking before surgery, whether 81 mg or 325 mg, doesn’t significantly change the restart timeline. What changes it is your cardiovascular risk profile and how your surgical site is healing. Your surgeon and cardiologist (if you have one) should coordinate on the specific day, since the decision sits at the intersection of bleeding risk and clotting risk that only they can weigh for your situation.